Iqvia Holdings (IQV) Cash & Equivalents Growth (3y) (2014 - 2026)
Iqvia Holdings (IQV) Cash & Equivalents Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | 9.06% |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | -20.26% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 14.02% |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | 15.43% |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | 11.37% |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | 39.74% |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | -12.51% |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | -14.97% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 70.63% |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn | 35.55% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.37% |
| Mar 31, 2026 | 9.23% |
| Dec 31, 2025 | 17.65% |
| Sep 30, 2025 | 12.50% |
| Jun 30, 2025 | 12.61% |
| Mar 31, 2025 | 7.85% |
| Dec 31, 2024 | 7.61% |
| Sep 30, 2024 | 2.26% |
| Jun 30, 2024 | -5.09% |
| Mar 31, 2024 | -14.43% |
| Dec 31, 2023 | -8.80% |
| Sep 30, 2023 | -5.79% |
| Jun 30, 2023 | 7.61% |
| Mar 31, 2023 | 17.24% |
| Dec 31, 2022 | 13.26% |
| Sep 30, 2022 | 13.86% |
| Jun 30, 2022 | 15.04% |
| Mar 31, 2022 | 14.01% |
| Dec 31, 2021 | 15.31% |
| Sep 30, 2021 | 21.14% |